Talaneh, Sasan, et al. “Treatment of Advanced Medullary Thyroid Cancer With an Alternating 5 FU-Dacarbazine”. International Pharmacy Acta, vol. 1, no. 1, Mar. 2018, pp. 157-8, doi:10.22037/ipa.v1i1.20501.